Orthologic Corp - Current report filing (8-K)
12 8월 2008 - 7:02PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
_______________________
Date of
Report: August 7, 2008
(Date of
earliest event reported)
ORTHOLOGIC
CORP
.
|
(Exact
name of registrant as specified in its
charter)
|
Delaware
|
|
000-21214
|
|
86-0585310
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
1275 West Washington Street, Tempe,
Arizona
|
|
85281
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(602)
286-5520
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Section
7 – Regulation FD
Item
7.01
|
Regulation
FD Disclosure
|
On August
7, 2008, OrthoLogic Corp. (the “Company”) announced by press release that
Chrysalin® (TP508) demonstrates significant benefit in a pre-clinical model of
Acute Heart Disease.
A copy of
the press release issued by the Company with respect to this matter is attached
hereto as Exhibit 99.1.
Section
9 – Financial Statements and Exhibits
Item
9.01
|
Financial
Statements and Exhibits.
|
|
Press
release dated August 7, 2008.
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: August
12, 2008
|
ORTHOLOGIC
CORP.
|
|
|
|
|
|
|
|
|
/s/ John M. Holliman, III
|
|
|
John
M. Holliman
|
|
|
Executive
Chairman
|
|
Orthologic (MM) (NASDAQ:OLGC)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Orthologic (MM) (NASDAQ:OLGC)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Orthologic (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Orthologic Corp News Articles